查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198497

中風後治療軟件市場——增長、趨勢、COVID-19 影響和預測 (2023-2028)

Stroke Post Processing Software Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 118 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內（2022 年至 2027 年），中風後治療軟件市場的複合年增長率預計為 8.55%。

在 COVID-19 大流行期間，大多數醫院護理轉向護理冠狀病毒感染的患者，導致短暫且略微放緩的增長。 然而，隨著 COVID 患者開始出現中風等腦部相關問題，對中風後治療軟件的需求增加。 然而，由於中風是一種敏感疾病，市場狀況很快就恢復了。 幫助管理中風後的軟件的可用性使一線工作人員能夠做出更好的治療決策。 由於技術進步，使用人工智能的中風管理軟件正在以相當大的勢頭傳播。 在 COVID-19 爆發之初，人們注□□意到中風患者的住院率有所下降。 這是因為我害怕在隔離和坐月子期間被感染。 許多地區都記錄了急性中風住院人數的減少，這表明許多輕度和重度中風患者也避免了住院治療。 根據美國國立衛生研究院 2020 年的數據，自發布與 COVID-19 相關的封鎖令以來，得克薩斯州中部和南部因急性中風護理而入院、治療和出院的人數急劇減少。我在這裡。

隨著中風次數的增加，中風管理系統和軟件的需求量越來越大。 根據美國疾病控制和預防中心 (CDC) 的數據，到 2020 年，美國六分之一的死亡人數預計將死於中風。 該軟件系統改善了中風患者的預後。 基於 AI 人工智能的方法可幫助中風專家檢測大血管閉塞，從而加快患者轉診和轉移速度。 中風後治療軟件可實現更有效的途徑、更快的治療決策並改善患者的治療效果。 技術改進，特別是在醫療保健 IT 解決方案領域，顯著提高了醫療保健專業人員對軟件的採用，並降低了中風後問題的可能性。

中風後護理軟件生成更詳細的圖像和同步數據，以幫助診斷中風的影響和進展，幫助醫生更快地做出臨床決策。 因此，對其進行質量升級和更新投資將對市場增長產生重大影響。 例如，GE Healthcare 的 ViewPoint 6 Direct Connect 醫院軟件通過自動填充超聲讀數和將詳細信息直接報告到放射學報告系統來減少聽寫，從而使醫生的生活更輕鬆。 根據美國疾病控制與預防中心的數據，2022 年美國每 40 秒就會發生一次中風。 此外，每 3.5 分鐘就有一人死於中風。 推動發達國家和新興國家採用醫療保健 IT 解決方案的政府政策是使該行業能夠改善醫療保健成果的關鍵因素。 醫療保健意識的提高、糖尿病患者數量的增加、煙草使用者數量的增加以及老年人口的增加是推動市場擴張的因素。

此外，中風檢測和治療方面的技術發展正在推動市場增長。 隨著醫療保健行業繼續依賴技術突破，人工智能和機器學習預計將變得司空見慣。 這為更複雜的檢測、診斷和治療中風患者的方法帶來了希望。 這將迫使服務提供商部署先進的中風後治療軟件。 然而，高昂的診斷和治療成本以及缺乏報銷監管預計將阻礙市場擴張。 另一方面，中風管理領域的持續研究和開發將為市場擴張提供有利可圖的潛力。 隨著人工智能和其他技術發展的普及，它們在關鍵醫療保健環境中的應用越來越廣泛。 所有這些因素都在推動預測期內市場的加速增長。

中風後治療軟件市場趨勢

腦卒中後治療軟件市場形態，MRI領域有望佔據主要市場份額

中風是一種嚴重影響患者生活質量的衰弱性疾病，如果不及時治療尤其如此。 中風的早期檢測可以減少患者殘廢的機會。 MRI 圖像提供頭部的清晰視圖，包括組織和血管。 MRI 使用磁場和射頻脈衝來揭示大腦中的任何變化。 市場按方式分為 CT 掃描和 MRI。 磁共振成像 (MRI) 是一種有用的診斷工具，可用於檢測影響血管和大腦的疾病，例如脊柱病變、癌症和中風。 脊柱疾病、癌症和中風患病率的上升預計將對市場的擴張做出重大貢獻。 對快速有效的診斷治療的需求不斷增長，預計將推動 MRI 設備的使用。 這些 MRI 機器安裝在多個國家/地區。 根據 2021 年 12 月的國家衛生服務更新，從 2020 年 9 月到 2021 年 8 月的 12 個月內，英格蘭報告了 4030 萬次影像學檢查。 其中，2021 年 8 月報告了 322 萬次成像測試。 2021 年 8 月，X 線平片檢查數量最多（160 萬例），其次是超聲診斷（超聲檢查，72 萬例）、計算機軸向斷層掃描（CT 掃描，49 萬例）和磁共振成像（MRI， 290,000 例）。

MRI 行業的發展得益於開放式 MRI、可視化軟件和超導磁體等診斷方法的進步。 MRI 技術的大部分最新進展都歸功於軟件。 這些軟件創新可加快對比增強掃描並促進成像程序。 不斷發展的 MRI 技術能夠快速檢測和診斷中風，有助於進行適當的管理。 擴散和擴散張量成像與纖維束成像、由 MR 波譜學組成的神經成像、灌注成像和採用大膽技術的功能成像預計將在整個預測期內推動市場增長。 此外，隨著術中 MRI 的發展取得進展，市場有望在整個預測期內擴大，並且已開始用於神經外科等各種應用。

北美將佔據很大的市場份額，預計在預測期內也會如此

預計北美將佔據很大一部分市場。 這是由於糖尿病等慢性病發病率的增加、對中風管理設備的需求增加、配備訓練有素的醫護人員的先進醫療設施的可用性以及許多大公司的研發活動增加。 ，部分原因是政府增加了對醫療保健系統的投資。 該地區慢性病尤其是神經系統疾病的患病率不斷上升，這增加了對圖像分析的需求。 預計該地區將在預測期內保持其主導地位。

技術進步和慢性病發病率的增加預計將在預測期內推動市場擴張。 因素包括中風患病率上升、患者人數顯著增加以及政府支持投資在該地區改善醫療保健設施。 根據美國衛生與公共服務部 2020 年數據，中風每年影響美國超過 795,000 人。 因此，美國和加拿大的醫院和專業組織越來越多地使用中風後治療軟件來幫助檢測動脈瘤和其他血管疾病。

隨著人工智能在中風診斷和治療中的應用取得進展，市場有望擴大。 由於患者數據處理新技術的引入，市場有望增長。 通過根據定制數據建立疾病模式，經過處理的患者數據可以專注於有患病風險的特定人群。 市場先驅可以通過提供可持續的醫療保健解決方案、使產品和服務更容易獲得以及應對數字中斷來擴大他們在新興市場的影響力。

中風後治療軟件市場競爭對手分析

中風後治療軟件市場分散且競爭激烈，由幾家大型企業組成。 從市場份額的角度來看，一些主要參與者目前主導著市場。 目前的市場主導者包括 Brainomix、Constant Therapy、Cozi、General Electric Company、Koninklijke Philips NV、Medisafe、RAPIDAI、Siemens Healthineers、Tactus Therapy Solutions Ltd 和 Viz.ai Inc。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 快速的技術進步
    • 增加政府對基因組學的資助
    • 個性化醫療的傳播
  • 市場製約因素
    • 缺乏技術工人
    • 設備成本高
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按技術
    • 聚合□鍊式反應 (PCR)
    • 下一代測序 (NGS)
    • 微陣列
    • 其他
  • 按產品類型
    • 設備
    • 試劑和耗材
    • 服務
  • 最終用戶
    • 藥物發現
    • 診斷研究所
    • 學術研究所
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • QIAGEN
    • Quest Diagnostics Incorporated
    • F. Hoffmann-La Roche Ltd
    • Illumina, Inc.
    • Novogene Corporation
    • PerkinElmer Inc.
    • Bio-Rad Laboratories
    • Thermo Fisher Scientific, Inc.
    • Agilent Technologies
    • Promega Corporation
    • Luminex Corporation

第七章市場機會與未來趨勢

簡介目錄
Product Code: 90830

The Stroke Post Processing Software Market is projected to register a CAGR of 8.55% during the forecast period (2022-2027).

During the COVID-19 pandemic, most of the hospital-based care was shifted to caring for coronavirus-infected patients, putting a transient and slight dent in growth. However, as more COVID patients suffered strokes and other brain-related issues, the demand for stroke post-processing software grew. Due to the sensitive nature of the stroke, however, market conditions recovered quickly. Frontline workers can now make better treatment decisions because of the availability of helpful post-stroke management software. AI-Artificial intelligence-driven stroke management software has seen a considerable surge in popularity because of technological improvements. Reduced hospital admissions of stroke patients were noted during the initial COVID-19 outbreak. It was because people were afraid of infection during a period of segregation and lockdown. A decline in acute stroke hospital admissions has been recorded in many regions, indicating that many patients with mild and severe strokes are also avoiding hospitalization. According to data from the National Institute of Health-2020, patient admission, treatment, and discharge volumes for acute stroke therapy in central and south Texas have reduced dramatically since COVID-19-related lockdown orders were issued.

Stroke management systems and software are in higher demand as the number of strokes rises. According to the Centers for Disease Control and Prevention (CDC), stroke is expected to account for one in every six deaths in the United States by 2020. The software systems provide better treatment outcomes for stroke victims. The AI-Artificial intelligence-based approach aids stroke specialists in detecting major vascular occlusions, allowing patients to be referred and transferred more quickly. The use of stroke post-processing software allows for the creation of more efficient pathways, faster treatment decisions, and improved patient outcomes. Technological improvements, particularly in the realm of healthcare IT solutions, have considerably improved software adoption by healthcare professionals while also lowering the likelihood of post-stroke problems.

The stroke post-processing software generates more detailed images with synchronized data, assisting in the diagnosis of the stroke's effect or progression and allowing physicians to make more rapid clinical judgments. As a result, investing in it to improve quality and updates can have a huge impact on market growth. For instance, Hospital software ViewPoint 6 Direct Connect by GE Healthcare helps reduce dictation by auto-populating ultrasound measurements and report details directly into the radiology reporting system and makes the physicians' work easier. According to the Centers for Disease Control and Prevention-2022, a stroke occurs every 40 seconds in the United States. Someone dies of a stroke every 3.5 minutes. In both developed and emerging nations, government policies that promote the overall adoption of healthcare IT solutions to improve healthcare outcomes operate as a primary reinforcing factor for the industry. Increased healthcare awareness, an increase in the frequency of diabetes, an increase in the number of tobacco users, and an increase in the senior population are all driving market expansion.

Furthermore, technical developments in stroke detection and treatment add to the market's growth. Artificial intelligence and machine learning are projected to become commonplace as the healthcare business continues to rely on technological breakthroughs. More sophisticated ways of detecting, diagnosing, and treating stroke patients are expected because of this. This will force service providers to implement highly advanced stroke post-processing software. However, high diagnostic and treatment costs, as well as a lack of reimbursement regulations, are projected to limit market expansion. On the other hand, continuous R&D in the field of stroke management is likely to provide the profitable potential for market expansion. Artificial intelligence and other technological developments have become more widely adopted across important healthcare settings as their penetration has increased. All the factors contribute to accelerating the market growth during the forecast period.

Stroke Post Processing Software Market Trends

The MRI Segment is Expected to Hold a Major Market Share for Modality in the Stroke Post Processing Software Market

A stroke is a debilitating ailment that has a significant impact on a patient's quality of life, especially if it is not treated promptly. Early detection of a stroke can lessen the likelihood of the patient surviving with a handicap. The head, including the tissue and blood vessels, can be seen clearly with MRI imaging. Magnetic fields and radiofrequency pulses are used in an MRI to reveal any alterations in the brain. The market is divided into CT scan and MRI segments based on modality. Magnetic resonance imaging (MRI) is a useful diagnostic tool for detecting disorders such as lesions in the spine, cancers, and strokes that affect the blood vessels and brain. The rising prevalence of lesions in the spine, cancers, and stroke disorders is likely to contribute significantly to market expansion. The increasing demand for speedy and effective diagnostic treatments is projected to drive MRI machine usage. These MRI equipment are being installed in several nations. According to the National Health Service updates from December 2021, there were 40.3 million imaging tests reported in England in the 12 months from September 2020 to August 2021. Of these, 3.22 million imaging tests were reported to have taken place in August 2021. In August 2021, Plain Radiography (X-ray) was most common (1.6 million), followed by Diagnostic Ultrasonography (Ultrasound, 0.72 million), Computerized Axial Tomography (CT Scan, 0.49 million), and Magnetic Resonance Imaging (MRI, 0.29 million).

The MRI industry is growing because of advancements in diagnostic approaches such as open MRI, visualization software, and superconducting magnets. The majority of the recent advancements in MRI technology have been in software. These software innovations make contrast scans faster and the imaging procedure easier. Growing MRI technology enables the fast detection and diagnosis of stroke and helps in proper management. Diffusion and diffusion tensor imaging with tractography, neuroimaging comprising MR spectroscopy, perfusion imaging, and functional imaging employing the bold technique are projected to drive market growth throughout the forecast period. Moreover, the market is predicted to increase due to the increasing development of intraoperative MRI and its use in various applications such as neurosurgery throughout the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to account for a sizable portion of the market. This is due to an increase in the incidence of chronic diseases like diabetes, an increase in demand for stroke management devices, the availability of advanced healthcare facilities with trained medical professionals, an increase in the number of R&D activities with a large presence of key players, and an increase in government investment in the healthcare system. The rising prevalence of chronic disorders, particularly neurological ailments, in this region drives up demand for imaging analysis. Throughout the predicted period, the region is likely to maintain its supremacy.

During the projected period, technological advancements combined with an increase in the incidence of chronic illnesses are expected to drive market expansion. Factors such as the increased stroke prevalence, massive patient population expansion, and supportive government investments in the creation of improved healthcare facilities in the region. Stroke affects more than 795,000 people in the United States each year, according to the United States Department of Health and Human Services 2020. As a result, hospitals and specialized institutions in the United States and Canada are increasingly using stroke post-processing software to help detect aneurysms and other vascular diseases.

The market is expected to benefit from the increased usage of artificial intelligence in the diagnosis and treatment of strokes. The market is expected to rise due to the introduction of newer technologies for patient data processing. By establishing a disease pattern from the tailored data, the processed patient data can focus on a specific group of people at risk of acquiring diseases. Market companies can expand their presence in developing countries by delivering sustainable healthcare solutions, making their products and services more accessible, and addressing digital difficulties.

Stroke Post Processing Software Market Competitor Analysis

The Stroke Post Processing Software Market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Brainomix, Constant Therapy, Cozi, General Electric Company, Koninklijke Philips NV, Medisafe, RAPIDAI, Siemens Healthineers, Tactus Therapy Solutions Ltd, and Viz.ai Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapid Technological Advancement
    • 4.2.2 Increased Government Funding towards Genomics
    • 4.2.3 Growing Adoption of Personalized Medicine
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Labor
    • 4.3.2 High Cost of the Instruments
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Technology
    • 5.1.1 Polymerase Chain Reaction (PCR)
    • 5.1.2 Next Generation Sequencing (NGS)
    • 5.1.3 Microarrays
    • 5.1.4 Others
  • 5.2 By Product Type
    • 5.2.1 Instruments
    • 5.2.2 Reagents and Consumables
    • 5.2.3 Services
  • 5.3 By End-user
    • 5.3.1 Drug Discovery
    • 5.3.2 Diagnostic Laboratories
    • 5.3.3 Academic Research Centers
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 QIAGEN
    • 6.1.2 Quest Diagnostics Incorporated
    • 6.1.3 F. Hoffmann-La Roche Ltd
    • 6.1.4 Illumina, Inc.
    • 6.1.5 Novogene Corporation
    • 6.1.6 PerkinElmer Inc.
    • 6.1.7 Bio-Rad Laboratories
    • 6.1.8 Thermo Fisher Scientific, Inc.
    • 6.1.9 Agilent Technologies
    • 6.1.10 Promega Corporation
    • 6.1.11 Luminex Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS